Cargando…
Epigenetic targeting of myeloid-derived suppressor cells: time to move into infectious diseases?
Autor principal: | Gjerstorff, Morten Frier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482232/ https://www.ncbi.nlm.nih.gov/pubmed/37680643 http://dx.doi.org/10.3389/fimmu.2023.1247715 |
Ejemplares similares
-
Crosstalk between interferon and interleukin-1 antiviral signaling in cancer cells: implications for immune evasion and therapeutic resistance
por: Gjerstorff, Morten Frier
Publicado: (2023) -
Advances in the study of myeloid-derived suppressor cells in infectious lung diseases
por: Zhang, Meng-Nan, et al.
Publicado: (2023) -
Novel Insights Into Epigenetic Reprogramming and Destabilization of Pericentromeric Heterochromatin in Cancer
por: Gjerstorff, Morten Frier
Publicado: (2020) -
Epigenetic modifications in the accumulation and function of myeloid-derived suppressor cells
por: Xu, Liangjie, et al.
Publicado: (2022) -
Myeloid-Derived Suppressor Cells: Ductile Targets in Disease
por: Consonni, Francesca Maria, et al.
Publicado: (2019)